Annual Reports in Medicinal Chemistry, 1st Edition,John Macor,ISBN9780123860095
Add to Wish List
 
 
 
Multi-Volume: Annual Reports in Medicinal Chemistry

Volume 46: Annual Reports in Medicinal Chemistry, 1st Edition

Print Book

Editor : J Macor  

Release Date:

Imprint: Academic Press

ISBN: 9780123860095

Pages: 624

Dimensions: 229 X 152

timely and critical reviews of important topics in medicinal chemistry

Buy print & eBook together
and save 40%

USD 171.00
Print Book

+

USD 166.00
eBook

USD 337.00Normal price

USD 202.20Bundle price

Add to Cart

Print Book Estimated Delivery Time

Paperback

USD 171.00
USD 85.50

In Stock

eBook eBook Overview

USD 166.00
USD 83.00

VST format

ePUB format

Add to Cart

Buy Print & eBook both and save 40%
View Bundle Price

 
 

Description

Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely new future therapies.

Readership

medicinal, pharmaceutical, and organic chemists

John Macor

Affiliations and Expertise

Neuroscience Discovery Chemistry, Bristol-Myers Squibb, USA

View additional works by John E. Macor

Annual Reports in Medicinal Chemistry, 1st Edition

1 mGlu4 Modulators Kevin Liu
2 Recent Advances towards Pain Therapeutics Philippe Nantermet
3 Circadian Rythym Paul Galatsis
4 Recent Progress in the Discovery of Kv7.x Modulators’ Ismet Dorange
5 Bile Acid Receptor Modulators for Treatment of Metabolic Diseases Yanping Xu
6 Mineralocorticoid Receptor Antagonists Katerina Leftheris
7 SGLT2 Inhibitors for the Treatment of Diabetes Jiwen Liu, TaeWeon Lee
8 CRTh2 Antagonists Laurence E. Burgess
9 Developments and Advances in Gastrointestinal Prokinetic Agents James W. Dale
10 Targeting Th17 and Treg Signaling Pathways in Autoimmunity Shomir Ghosh
11 Advances in the Discovery of C5a Receptor Antagonists Jay P. Powers
12 Inhibition of Translation Initiation as a Novel Paradigm for Cancer
13 The Development of Inhibitor of Apoptosis Protein Antagonists for the Treatment of Resistant Cancers. Stephen Condon
14 Case History on the Discovery of Halaven® Melvin Lu
15 Emerging New Therapeutics against Key Gram-negative Pathogens Daniel Obrecht
16 Hepatitis C Virus Inhibitors - Beyond NS3 Protease and NS5B
17 The Emergence of Small Molecule Modulators of the Capsid Assembly Pathway as Potential Antiviral Therapeutics Clarence R. Hurt 
18 Mechanism of Action (MoA) in Drug Discovery David Swinney
19 Aryl Hydrocarbon Receptor (AhR) Activation: An Emerging
20 Prolyl Isomerases Pat Flaherty
21 Potential Therapeutic Applications of miRNA Graham Brock
22 Induced Pluripotent Stem Cells (iPSC) as Drug Discovery Tools and Human Disease Models Charles R. Johnson
23 Progress in Drug Repositioning: Old Drugs, New Opportunities Michael A. Walters
24 Deuterium in Drug Discovery and Development Scott L. Harbeson
25 Phospholipidosis Peter Bernstein
26 To Market, To Market 2010 Joanne Bronson

Quotes and reviews

This series is one of the very few annual publications which justify the title of an absolute must for the pharmacologist, chemist, or physician who is interested in the chemistry of drug development." - ENZYMOLOGIA

»
Annual Reports in Medicinal Chemistry